More articles from Minireviews

You have access
A Decade in the MIST: Learnings from Investigations of Drug Metabolites in Drug Development under the “Metabolites in Safety Testing” Regulatory Guidance
Simone Schadt, Bojan Bister, Swapan K. Chowdhury, Christoph Funk, Cornelis E. C. A. Hop, W. Griffith Humphreys, Fumihiko Igarashi, Alexander D. James, Mark Kagan, S. Cyrus Khojasteh, Angus N. R. Nedderman, Chandra Prakash, Frank Runge, Holger Scheible, Douglas K. Spracklin, Piet Swart, Susanna Tse, Josh Yuan and R. Scott Obach

Drug Metabolism and Disposition June 2018, 46 (6) 865-878; DOI: https://doi.org/10.1124/dmd.117.079848
You have access
Risk of Clinically Relevant Pharmacokinetic-Based Drug-Drug Interactions with Drugs Approved by the U.S. Food and Drug Administration Between 2013 and 2016
Jingjing Yu, Zhu Zhou, Jessica Tay-Sontheimer, René H. Levy and Isabelle Ragueneau-Majlessi

Drug Metabolism and Disposition June 2018, 46 (6) 835-845; DOI: https://doi.org/10.1124/dmd.117.078691
You have access
What Can Be Learned from Recent New Drug Applications? A Systematic Review of Drug Interaction Data for Drugs Approved by the US FDA in 2015
Jingjing Yu, Zhu Zhou, Katie H. Owens, Tasha K. Ritchie and Isabelle Ragueneau-Majlessi

Drug Metabolism and Disposition January 2017, 45 (1) 86-108; DOI: https://doi.org/10.1124/dmd.116.073411
You have access
CHOLESTEROL-METABOLIZING CYTOCHROMES P450
Irina A. Pikuleva

Drug Metabolism and Disposition April 2006, 34 (4) 513-520; DOI: https://doi.org/10.1124/dmd.105.008789
You have access
MECHANISM-BASED INACTIVATION AND REVERSIBILITY: IS THERE A NEW TREND IN THE INACTIVATION OF CYTOCHROME P450 ENZYMES?
Anna L. Blobaum

Drug Metabolism and Disposition January 2006, 34 (1) 1-7; DOI: https://doi.org/10.1124/dmd.105.004747
You have access
THREE-DIMENSIONAL QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP ANALYSIS OF CYTOCHROMES P450: EFFECT OF INCORPORATING HIGHER-AFFINITY LIGANDS AND POTENTIAL NEW APPLICATIONS
Charles W. Locuson and Jan L. Wahlstrom

Drug Metabolism and Disposition July 2005, 33 (7) 873-878; DOI: https://doi.org/10.1124/dmd.105.004325
You have access
METABOLISM-BASED DRUG-DRUG INTERACTIONS: WHAT DETERMINES INDIVIDUAL VARIABILITY IN CYTOCHROME P450 INDUCTION?
Cuyue Tang, Jiunn H. Lin and Anthony Y. H. Lu

Drug Metabolism and Disposition May 2005, 33 (5) 603-613; DOI: https://doi.org/10.1124/dmd.104.003236
You have access
DRUG-DRUG INTERACTIONS FOR UDP-GLUCURONOSYLTRANSFERASE SUBSTRATES: A PHARMACOKINETIC EXPLANATION FOR TYPICALLY OBSERVED LOW EXPOSURE (AUC_I/AUC) RATIOS
J. Andrew Williams, Ruth Hyland, Barry C. Jones, Dennis A. Smith, Susan Hurst, Theunis C. Goosen, Vincent Peterkin, Jeffrey R. Koup and Simon E. Ball

Drug Metabolism and Disposition November 2004, 32 (11) 1201-1208; DOI: https://doi.org/10.1124/dmd.104.000794
You have access
JUD COON: 35 YEARS OF P450 RESEARCH, A SYNOPSIS OF P450 HISTORY
Todd D. Porter

Drug Metabolism and Disposition January 2004, 32 (1) 1-6; DOI: https://doi.org/10.1124/dmd.32.1.1

Main menu

User menu

Search

More articles from Minireviews

Navigate

More Information

ASPET's Other Journals